Works matching IS 17597706 AND DT 2022 AND VI 13 AND IP 3

Results: 35

Uniportal video‐assisted thoracic surgery approach for simultaneous lung cancer and thymic carcinoma: Case report and literature review.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 489, doi. 10.1111/1759-7714.14258
By:
- Frasca, Luca;
- Tacchi, Giovanni;
- Longo, Filippo;
- Marziali, Valentina;
- De Peppo, Valerio;
- Moscardelli, Alessandro;
- Crucitti, Pierfilippo
Publication type:
Article
Dramatic response to immunochemotherapy followed by salvage surgery in an elderly lung cancer patient.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 510, doi. 10.1111/1759-7714.14293
By:
- Okano, Yoshio;
- Kunishige, Michihiro;
- Kondo, Yoshihiro;
- Kadota, Naoki;
- Morishita, Atsushi;
- Naruse, Keishi;
- Machida, Hisanori;
- Hatakeyama, Nobuo;
- Hino, Hiroyuki;
- Shinohara, Tsutomu;
- Sakiyama, Shoji;
- Takeuchi, Eiji
Publication type:
Article
Reconstruction of the trachea and carina: Surgical reconstruction, autologous tissue transplantation, allograft transplantation, and bioengineering.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 284, doi. 10.1111/1759-7714.14315
By:
- Ren, Jianghao;
- Xu, Yuanyuan;
- Zhiyi, Guo;
- Ren, Ting;
- Ren, Jiangbin;
- Wang, Kan;
- Luo, Yiqing;
- Zhu, Mingyang;
- Tan, Qiang
Publication type:
Article
Combined targeting of EGFR and BRAF triggers regression of osimertinib resistance by using osimertinib and vemurafenib concurrently in a patient with heterogeneity between different lesions.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 514, doi. 10.1111/1759-7714.14295
By:
- Sun, Mengyao;
- Wang, Xu;
- Xu, Yinghui;
- Sun, Chao;
- Guo, Ye;
- Qiu, Shi;
- Zhao, Renshan;
- Zhu, Wenhao;
- Ma, Kewei
Publication type:
Article
Left sleeve pneumonectomy via uniportal video‐assisted thoracoscopic approach.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 506, doi. 10.1111/1759-7714.14292
By:
- Cai, Jianqiao;
- Song, Nan;
- Jiang, Lei
Publication type:
Article
Use of PD‐1 inhibitor tislelizumab in the treatment of advanced pulmonary sarcomatoid carcinoma: A case report.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 502, doi. 10.1111/1759-7714.14290
By:
- Xu, Li;
- Tao, Ning‐ning;
- Liang, Bin;
- Li, Dao‐wei;
- Li, Huai‐chen;
- Su, Li‐li
Publication type:
Article
miR‐223‐3p targets FBXW7 to promote epithelial‐mesenchymal transition and metastasis in breast cancer.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 474, doi. 10.1111/1759-7714.14284
By:
- Wang, Yuli;
- Shi, Shuang;
- Wang, Yunshan;
- Zhang, Xuhua;
- Liu, Xiaoyan;
- Li, Juan;
- Li, Peilong;
- Du, Lutao;
- Wang, Chuanxin
Publication type:
Article
Preoperative electromagnetic navigation bronchoscopy‐guided one‐stage multiple‐dye localization for resection of subsolid nodules: A single‐center pilot study.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 466, doi. 10.1111/1759-7714.14283
By:
- Jeong, Jong Hwan;
- Park, Hyeongbin;
- Choi, Chang‐Min;
- Oh, Ju Hyun;
- Lee, Geun Dong;
- Kim, Dong Kwan;
- Hwang, Hee Sang;
- Jang, Se Jin;
- Oh, Sang Young;
- Kim, Mi Young;
- Ji, Wonjun
Publication type:
Article
Differential diagnosis of lung cancer and benign lung lesion using salivary metabolites: A preliminary study.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 460, doi. 10.1111/1759-7714.14282
By:
- Takamori, Satoshi;
- Ishikawa, Shigeo;
- Suzuki, Jun;
- Oizumi, Hiroyuki;
- Uchida, Tetsuro;
- Ueda, Shohei;
- Edamatsu, Kaoru;
- Iino, Mitsuyoshi;
- Sugimoto, Masahiro
Publication type:
Article
Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 442, doi. 10.1111/1759-7714.14280
By:
- Feng, Yuan;
- Sun, Wei;
- Zhang, Jie;
- Wang, Yang;
- Chen, Jinfeng;
- Liu, Xinying;
- Wang, Liang;
- Li, Shaolei;
- Lv, Chao;
- Lu, Fangliang;
- Zhang, Jianzhi;
- Hong, Yang;
- Xiao, Shanshan;
- Wang, Tao;
- Jiao, Raymond;
- Wang, Ziping;
- Qi, Liping;
- Li, Nan;
- Yang, Yue;
- Lin, Dongmei
Publication type:
Article
Short‐term safety of an anti‐severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 453, doi. 10.1111/1759-7714.14281
By:
- Tamura, Tomoki;
- Ninomiya, Kiichiro;
- Kubo, Toshio;
- Kuyama, Shoichi;
- Tachibana, Sayaka;
- Inoue, Koji;
- Chikamori, Kenichi;
- Kudo, Kenichiro;
- Ochi, Nobuaki;
- Harada, Daijiro;
- Maeda, Yoshinobu;
- Kiura, Katsuyuki
Publication type:
Article
MiR‐192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF‐κB pathway.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 430, doi. 10.1111/1759-7714.14278
By:
- Li, Yang;
- Zu, Lingling;
- Wu, Heng;
- Zhang, Fang;
- Fan, Yaguang;
- Pan, Hongli;
- Du, Xinxin;
- Guo, Fengjie;
- Zhou, Qinghua
Publication type:
Article
Successful immune checkpoint inhibitor‐based rechallenge in a patient with advanced esophageal squamous cell cancer: A case report.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 497, doi. 10.1111/1759-7714.14279
By:
- Yao, Yanhong;
- Liu, Zhentao;
- Li, Qian;
- Cao, Baoshan;
- Wang, Mopei
Publication type:
Article
Update on adjuvant therapy in completely resected NSCLC patients.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 277, doi. 10.1111/1759-7714.14277
By:
- Lim, Jeong Uk;
- Yeo, Chang Dong
Publication type:
Article
Successful erlotinib rechallenge in an EGFR‐mutant metastatic non‐small cell lung cancer patient with afatinib‐induced drug rash with eosinophilia and systemic symptoms: A case report.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 494, doi. 10.1111/1759-7714.14276
By:
- Lin, Chung‐Fu;
- Liu, Szu‐Yu;
- Lo, Tzu‐Kun;
- Lee, Julia Yu‐Yun;
- Su, Po‐Lan
Publication type:
Article
Immune checkpoint inhibitor‐related adverse events in lung cancer: Real‐world incidence and management practices of 1905 patients in China.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 412, doi. 10.1111/1759-7714.14274
By:
- Shi, Yuequan;
- Fang, Jian;
- Zhou, Chengzhi;
- Liu, Anwen;
- Wang, Yan;
- Meng, Qingwei;
- Ding, Cuimin;
- Ai, Bin;
- Gu, Yangchun;
- Yao, Yu;
- Sun, Hong;
- Guo, Hui;
- Zhang, Cuiying;
- Song, Xia;
- Li, Junling;
- Xu, Bei;
- Han, Zhiqiang;
- Song, Meijun;
- Tang, Tingyu;
- Chen, Peifeng
Publication type:
Article
"Split" combined subsegmentectomy: A case series.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 423, doi. 10.1111/1759-7714.14275
By:
- Hong, Ruopeng;
- Chen, Chun;
- Zheng, Wei;
- Zheng, Bin;
- Xu, Chi;
- Xu, Guobing
Publication type:
Article
Postoperative radiotherapy improves survival of patients with ypN2 non‐small cell lung cancer after neoadjuvant chemotherapy followed by surgery – A propensity score matching study of the Surveillance, Epidemiology, and End Results database.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 404, doi. 10.1111/1759-7714.14273
By:
- Bao, Yongxing;
- Yang, Xu;
- Men, Yu;
- Kang, Jingjing;
- Sun, Xin;
- Zhao, Maoyuan;
- Sun, Shuang;
- Yuan, Meng;
- Ma, Zeliang;
- Hui, Zhouguang
Publication type:
Article
Immunotherapy plus chemotherapy showed superior clinical benefit to chemotherapy alone in advanced NSCLC patients after progression on osimertinib.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 394, doi. 10.1111/1759-7714.14271
By:
- Long, Yaping;
- Xiong, Qi;
- Song, Qi;
- Li, Yao;
- Li, Xiaoyan;
- Qin, Boyu;
- Huang, Ziwei;
- Hu, Yi;
- Yang, Bo
Publication type:
Article
Tumor‐associated macrophages: An important player in breast cancer progression.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 269, doi. 10.1111/1759-7714.14268
By:
- Huang, Xinqun;
- Cao, Jingsong;
- Zu, Xuyu
Publication type:
Article
Treatment with immune checkpoint inhibitors after EGFR‐TKIs in EGFR‐mutated lung cancer.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 386, doi. 10.1111/1759-7714.14267
By:
- Ito, Takashi;
- Nagashima, Hiromi;
- Akiyama, Masachika;
- Utsumi, Yu;
- Sato, Hideomi;
- Chiba, Shinji;
- Sugai, Mayu;
- Ube, Kenji;
- Mori, Yoshiaki;
- Watanabe, Kana;
- Fukuhara, Tatsuro;
- Maemondo, Makoto
Publication type:
Article
Multicenter real‐world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non‐small cell lung cancer.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 380, doi. 10.1111/1759-7714.14266
By:
- Lee, Su Yeon;
- Kim, Young Chul;
- Lee, Kye Young;
- Lee, Sung Yong;
- Lee, Shin Yup;
- Lee, Min Ki;
- Lee, Jeong Eun;
- Jang, Seung Hun;
- Jang, Tae‐Won;
- Choi, Chang Min
Publication type:
Article
High GNG4 expression is associated with poor prognosis in patients with lung adenocarcinoma.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 369, doi. 10.1111/1759-7714.14265
By:
- Zhou, Bodong;
- Zhu, Wenbo;
- Yuan, Shuai;
- Wang, Yifei;
- Zhang, Qing;
- Zheng, Hong;
- Zhu, Lei;
- Xu, Jie
Publication type:
Article
Low baseline plasma PCSK9 level is associated with good clinical outcomes of immune checkpoint inhibitors in advanced non‐small cell lung cancer.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 353, doi. 10.1111/1759-7714.14259
By:
- Xie, Mengqing;
- Yu, Xin;
- Chu, Xiangling;
- Xie, Huikang;
- Zhou, Juan;
- Zhao, Jing;
- Su, Chunxia
Publication type:
Article
Risk factors for pulmonary complications after neoadjuvant chemoradiotherapy followed by surgery for non‐small cell lung cancer.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 361, doi. 10.1111/1759-7714.14263
By:
- Kim, Ha Eun;
- Yu, Woo Sik;
- Lee, Chang Young;
- Lee, Jin Gu;
- Kim, Dae Joon;
- Park, Seong Yong
Publication type:
Article
Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 483, doi. 10.1111/1759-7714.14256
By:
- Banna, Giuseppe L.;
- Tiseo, Marcello;
- Cortinovis, Diego L.;
- Facchinetti, Francesco;
- Aerts, Joachim G. J. V.;
- Baldessari, Cinzia;
- Giusti, Raffaele;
- Bria, Emilio;
- Grossi, Francesco;
- Berardi, Rossana;
- Morabito, Alessandro;
- Catino, Annamaria;
- Genova, Carlo;
- Mazzoni, Francesca;
- Gelibter, Alain;
- Rastelli, Francesca;
- Macerelli, Marianna;
- Chiari, Rita;
- Gori, Stefania;
- Mansueto, Giovanni
Publication type:
Article
Optimal duration of adjuvant bisphosphonate treatment for high‐risk early breast cancer: Results from a SUCCESS trial.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 519, doi. 10.1111/1759-7714.14257
By:
- Lu, Mingbei;
- Ren, Beibei;
- Rao, Lingyan
Publication type:
Article
Does size affect the prognosis of resectable thymoma beyond the eighth edition TNM?
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 346, doi. 10.1111/1759-7714.14255
By:
- Tseng, Yen‐Chiang;
- Hsu, Han‐Shui;
- Lin, Yi‐Hsuan;
- Tseng, Yen‐Han;
- Shu, Chih‐Wen;
- Goan, Yih‐Gang;
- Tseng, Ching‐Jiunn
Publication type:
Article
ASCL1 and DLL3 expressions and their clinicopathological implications in surgically resected pure small cell lung cancer: A study of 247 cases from the National Cancer Center of China.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 338, doi. 10.1111/1759-7714.14249
By:
- Hu, Chunfang;
- Dong, Jiyan;
- Liu, Li;
- Liu, Jingbo;
- Sun, Xujie;
- Teng, Fei;
- Wang, Xin;
- Ying, Jianming;
- Li, Junling;
- Xing, Puyuan;
- Yang, Lin
Publication type:
Article
Efficacy and safety of anti‐PD‐1/PD‐L1 in combination with chemotherapy or not as first‐line treatment for advanced non‐small cell lung cancer: A systematic review and network meta‐analysis.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 322, doi. 10.1111/1759-7714.14244
By:
- Wang, Liming;
- Yang, Yifan;
- Yu, Jiangyong;
- Zhang, Shuai;
- Li, Xu;
- Wu, Xiaonan;
- Nie, Xin;
- Liu, Wenbo;
- Zhang, Ping;
- Li, Yi;
- Li, Ailing;
- Ai, Bin
Publication type:
Article
Colorectal cancer‐related pulmonary metastasectomy: Factors affecting survival time.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 517, doi. 10.1111/1759-7714.14240
By:
- Williams, Norman R.;
- Macbeth, Fergus;
- Treasure, Tom
Publication type:
Article
MicroRNA‐21 was a promising biomarker for lung carcinoma diagnosis: An update meta‐analysis.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 316, doi. 10.1111/1759-7714.14242
By:
- Wang, Haiyan;
- Xu, Jia;
- Ding, Ling
Publication type:
Article
Development and validation of a prediction model using molecular marker for long‐term survival in unresectable stage III non‐small cell lung cancer treated with chemoradiotherapy.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 296, doi. 10.1111/1759-7714.14218
By:
- Yang, Yufan;
- Zhang, Tao;
- Zhou, Zongmei;
- Liang, Jun;
- Chen, Dongfu;
- Feng, Qinfu;
- Xiao, Zefen;
- Hui, Zhouguang;
- Lv, Jima;
- Deng, Lei;
- Wang, Xin;
- Wang, Wenqing;
- Wang, Jianyang;
- Liu, Wenyang;
- Zhai, Yirui;
- Wang, Jie;
- Bi, Nan;
- Wang, Luhua
Publication type:
Article
Effect of physical manipulation pulmonary rehabilitation on lung cancer patients after thoracoscopic lobectomy.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 308, doi. 10.1111/1759-7714.14225
By:
- Zhou, Ting;
- Sun, Chao
Publication type:
Article
Issue Information.
Published in:
Thoracic Cancer, 2022, v. 13, n. 3, p. 267, doi. 10.1111/1759-7714.14017
Publication type:
Article